Lauren Buchanan, MA, Managing Editor

In a world where she practices dermatology, conducts research, and is a super mom, Alina Bridges, DO has nailed down a strategy to not let emails stress her out.

A review on breast cancer screenings and procedures on the chest is essential to ensure proper gender-affirming care.

The impacts of discrimination, harassment, and microaggressions have lasting impact on a clinician’s performance, mental health, and career. Here’s how to create a respectful culture.

The latest phase 3 trial results were showcased in an AAD late-breaking research session.

Wu delves into her AAD involvement as she presents in sessions centered around the importance of patch testing and how clinical guidelines are created.

She and her colleagues illustrated the role of direct immunofluorescence plays in the evaluation of autoimmune blistering disorders.

The Skin of Color Society challenged dermatologists, residents, and medical students to address racial disparities in dermatologic care and shared best practices to serve patients of color.

The Dermatology Times® team is in New Orleans, Louisiana to showcase innovative solutions in dermatologic care.

Anna Bar, MD, FAAD returns to AAD as part of the interactive “How Would You Reconstruct It?” session.

In conjunction with AAD 2023, the Skin of Color Society presents an opportunity to learn about racial disparities in dermatologic care and best practices to serve patients of color.

Treatment safety and efficacy for atopic dermatitis has seen significant growth over the last decade.

The findings of this cross-sectional study indicate alopecia areata, alopecia totalis, and alopecia universalis is more common in people of color, particularly Asian Americans.

The AbbVie company announced their partnership with the grant program to encourage women to own their own businesses.

The treatment for adults and adolescents with the type 2 inflammatory skin condition has been accepted for FDA review.

The commander-in-chief’s cancerous tissue was successfully removed last month.

Today is Rare Disease Day. The Food and Drug Administration (FDA) defined a rare disease as a condition affecting less than 200,000 people in the United States.

Study participants saw a rapid decrease in inflammatory lesions with the once-daily antibiotic, antibacterial, and retinoid gel.

Look back at 10 of the innovative sessions presented at the 2023 Winter Clinical Hawaii Conference in Kohala Coast, Hawaii.

The AMBLor test is the first of its kind to identify the progression of melanomas.

Shop Me Ca of Herndon, Virginia recalled its 10-gram tubes of Diep Bao Cream due to potential lead contamination.

An additional batch of sunscreen has been added to the recall first announced on July 29, 2022 for the presence of benzene.

A recent study shows patients with moderate-to-severe plaque psoriasis grew to be more productive at work with tildrakizumab treatment over time.

Enjoy fun in the sun when Maui Derm Hawaii 2023 presentations aren’t in session.

Cytokine-expressing genes were silenced in a recent Vanderbilt University Medical Center study.

The non-invasive treatment has no downtime for patients.

The year-long study gives insight to the treatment’s efficacy and safety of durability.

Phase 3 studies show upadacitinib is safe in the treatment of moderate-to-severe cases of eczema.